乙卡尼丁的异构分离特征揭示了2型糖尿病的变化
Xiangyu Gao1, Chunli Liu2, Xue Zhao3
1College of Energy Materials and Chemistry, Inner Mongolia University, Hohhot, 010070, Inner Mongolia, China.
Analytica chimica acta
|April 5, 2025
概括
这项研究使用LC-MS/MS增强了乙卡尼丁 (CAR) 检测,使得详细的结构分析成为可能. 新的方法在小鼠血中确定了CAR异构体,揭示了潜在的2型糖尿病生物标志物.
科学领域:
- 代谢学 代谢学 代谢学
- 分析化学 分析化学
- 生物化学 生物化学
背景情况:
- 乙卡尼丁 (CARs) 是细胞能量代谢中的重要脂肪酸代谢产物.
- 对各种CAR物种的详细结构特征仍然具有挑战性.
- HPLC-ESI-MS是CAR分析的标准技术.
研究的目的:
- 改进大质谱 (MS) 检测信号,用于CARs.
- 开发方法来详细阐明CAR的结构,包括修改和双重债券头寸.
- 在复杂的生物样本中对CAR进行分析,并确定潜在的疾病生物标志物.
主要方法:
- 通过将二碳酸缓冲剂添加到LC移动阶段来增强CAR检测.
- 利用电子激活解离 (EAD) 来定位基和甲基分支.
- 采用帕特诺-布奇 (PB) 反应来衍生碳-碳双键 (CC).
主要成果:
- 实现了对CAR的MS检测信号的改进.
- 在CAR中,EAD成功地定位了基和甲基分支.
- 在PB衍生中,在不和CAR中确定了CC仓位.
- 在小鼠血中详细的CAR分析揭示了同位素组成.
- 在2型糖尿病 (T2D) 样本中观察到特定CAR异构体的显著变化.
结论:
- 碳酸可以提高LC系统中的CAR检测极限.
- 与MS相结合的PB衍生确定了CAR中的CC位置.
- EAD局部化了像甲基分支和基团这样的链修饰.
- 该研究为详细的CAR结构分析提供了一个强大的方法.
- 已识别的CAR异构体变化表明它们可能是T2D诊断指标.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...


